EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte Studie

Long‐term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes

Manijeh Noori iD, Evald Høj Christiansen, Bent Raungaard, Anders Junker, Martin Kirk Christensen, Johnny Kahlert, Michael Maeng, Phillip Freeman, Kirstine Nørregaard Hansen, Christian Juhl Terkelsen, Julia Ellert-Gregersen, Steen Dalby Kristensen and 3 more

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.30937 ↗

At a glance

Randomisierte kontrollierte Studie in Catheterization and Cardiovascular Interventions, 2024. Written by Manijeh Noori and 14 co-authors. Institution: Department of Cardiology, Odense University Hospital, Odense, Denmark. Major MEDLINE topics: Coronary Artery Disease, Acute Coronary Syndrome, Drug-Eluting Stents, Cardiovascular Agents. Cited 2 times so far (Crossref); 33 references. Funded by: Terumo, Tokyo, Japan, Biotronik, Bülach, Switzerland.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Patients with acute coronary syndromes (ACS) may have worse outcomes after percutaneous coronary intervention compared to patients without ACS.

Aims

To compare 5‐year efficacy and safety outcomes in patients with and without ACS treated with biodegradable polymers, the ultrathin strut sirolimus‐eluting Orsiro stent (O‐SES) or the biolimus‐eluting Nobori stent (N‐BES).

Methods

The Scandinavian Organisation for Randomized Trials with Clinical Outcome VII is a randomized trial comparing O‐SES and N‐BES in an all‐comer setting. Of 2525 patients, 1329 (53%) patients had ACS and 1196 (47%) patients were without ACS. Endpoints were target lesion failure (TLF) (a composite of cardiac death, target lesion myocardial infarction, or target lesion revascularization) and definite stent thrombosis within 5 years.

Results

At 5‐year follow‐up, TLF did not differ significantly between patients with and without ACS (12.3% vs. 13.2%; rate ratio (RR) 1.00; 95% confidence interval (CI): 0.70–1.44), whereas the risk of definite stent thrombosis was increased in patients with ACS (2.3% vs. 1.3; RR: 2.01 [95% CI: 1.01–3.98]). In patients with ACS, the rate of TLF was similar between O‐SES and N‐BES (12.4% vs. 12.3%; RR: 1.02; 95% CI: 0.74–1.40). The reduced risk of definite stent thrombosis in O‐SES treated ACS patients within the first year (0.2% vs. 1.6%; RR: 0.12; 95% CI: 0.02–0.93) was not maintained after 5 years (1.8% vs. 2.7%; RR: 0.77; 95% CI: 0.37–1.63).

Conclusion

Patients with ACS had an increased risk of stent thrombosis regardless of the stent type used. Long‐term outcomes were similar for ACS patients treated with O‐SES or N‐BES at 5 years.

Subjects

MeSH terms (MEDLINE)

Coronary Artery DiseaseAcute Coronary SyndromeDrug-Eluting StentsCardiovascular AgentsCoronary ThrombosisPercutaneous Coronary InterventionAlkanesulfonic AcidsHumansRisk FactorsTreatment OutcomeAbsorbable ImplantsProsthesis DesignStentsPolymers

Author keywords

biodegradable polymersbiolimuscoronary stentsmyocardial infarctionsirolimusstent thrombosistarget lesion failuretarget lesion revascularization

Substances

BESCardiovascular AgentsPolymersAlkanesulfonic Acids

Authors and institutions

  • Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.

ORCID profiles: Manijeh Noori

Funding

  • Terumo, Tokyo, Japan
  • Biotronik, Bülach, Switzerland

Cite

APA

Noori, M., Christiansen, E. H., Raungaard, B., Junker, A., Christensen, M. K., Kahlert, J., Maeng, M., Freeman, P., Hansen, K. N., Terkelsen, C. J., Ellert-Gregersen, J., Kristensen, S. D., Veien, K. T., Jakobsen, L., & Jensen, L. O. (2024). Long‐term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30937

Vancouver

Noori M, Christiansen EH, Raungaard B, Junker A, Christensen MK, Kahlert J, et al. Long‐term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.30937

BibTeX
@article{Noori2024,
  author = {Noori, Manijeh and Christiansen, Evald Høj and Raungaard, Bent and Junker, Anders and Christensen, Martin Kirk and Kahlert, Johnny and Maeng, Michael and Freeman, Phillip and Hansen, Kirstine Nørregaard and Terkelsen, Christian Juhl and Ellert-Gregersen, Julia and Kristensen, Steen Dalby and Veien, Karsten Tange and Jakobsen, Lars and Jensen, Lisette Okkels},
  title = {Long‐term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.30937}
}
Start for free →